Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus
© Devoto et al; licensee BioMed Central Ltd. 2005
Received: 01 December 2004
Accepted: 02 May 2005
Published: 02 May 2005
Previous studies by our group suggest that extracellular dopamine (DA) and noradrenaline (NA) may be co-released from noradrenergic nerve terminals in the cerebral cortex. We recently demonstrated that the concomitant release of DA and NA could be elicited in the cerebral cortex by electrical stimulation of the locus coeruleus (LC). This study analyses the effect of both single train and repeated electrical stimulation of LC on NA and DA release in the medial prefrontal cortex (mPFC), occipital cortex (Occ), and caudate nucleus. To rule out possible stressful effects of electrical stimulation, experiments were performed on chloral hydrate anaesthetised rats.
Twenty min electrical stimulation of the LC, with burst type pattern of pulses, increased NA and DA both in the mPFC and in the Occ. NA in both cortices and DA in the mPFC returned to baseline within 20 min after the end of the stimulation period, while DA in the Occ reached a maximum increase during 20 min post-stimulation and remained higher than baseline values at 220 min post-stimulation. Local perfusion with tetrodotoxin (TTX, 10 μM) markedly reduced baseline NA and DA in the mPFC and Occ and totally suppressed the effect of electrical stimulation in both areas.
A sequence of five 20 min stimulations at 20 min intervals were delivered to the LC. Each stimulus increased NA to the same extent and duration as the first stimulus, whereas DA remained elevated at the time next stimulus was delivered, so that baseline DA progressively increased in the mPFC and Occ to reach about 130 and 200% the initial level, respectively.
In the presence of the NA transport (NAT) blocker desipramine (DMI, 100 μM), multiple LC stimulation still increased extracellular NA and DA levels.
Electrical stimulation of the LC increased NA levels in the homolateral caudate nucleus, but failed to modify DA level.
The results confirm and extend that LC stimulation induces a concomitant release of DA and NA in the mPFC and Occ.
The different time-course of LC-induced elevation of DA and NA suggests that their co-release may be differentially controlled.
Noradrenergic neurons in the locus coeruleus (LC) project homogeneously throughout the cerebral cortex, while dopaminergic afferents are mainly confined to discrete areas of the cortex, such as the medial prefrontal cortex (mPFC), anterior cingulate, rhinal and entorhinal cortices [1, 2]. However, even in cortical areas where dopaminergic and noradrenergic innervations converge, such as the mPFC, tissue noradrenaline (NA) concentrations exceed those of dopamine (DA). Furthermore, in the cerebral cortex a consistent mismatch exists between DA receptor distribution and dopaminergic innervation, DA receptors being widely expressed in non-innervated areas [3–7].
Previous evidence from our laboratory has suggested the possibility that DA in the cerebral cortex may be released other than from dopaminergic terminals also from noradrenergic ones, where DA acts both as NA precursor and co-transmitter [8–12]. This hypothesis is supported by the fact that extracellular DA concentrations in cortical areas scarcely innervated by the meso-cortical dopaminergic pathway, such as the occipital (Occ) and parietal cortices, were found to be only slightly lower than in the mPFC, an area with massive dopaminergic afferents .
Moreover, extracellular DA in different cortices was found to be modified by drugs acting on noradrenergic transmission but not, or only modestly, by drugs modifying dopaminergic activity [9–11]. Thus, consistent with its ability to inhibit noradrenergic activity, the α2-adrenoceptor agonist clonidine produced a concomitant reduction in extracellular DA and NA both in the mPFC and Occ, whereas the α2-adrenoceptor antagonists idazoxan and RS 79948 produced a concomitant increase in extracellular NA and DA in both cortices [10, 11]. Moreover, local infusion into the LC of carbachol, kainic acid or N-methyl aspartic acid increased both NA and DA in the mPFC, in accord with their ability to activate noradrenergic neurons .
In a previous study  we demonstrated that extracellular NA and DA in the cerebral cortex are increased by electrical stimulation of the LC in a frequency dependent manner. However, the higher frequency patterns tested elicited a robust behavioural activation, and even at low frequencies animals displayed a state of alert with fine muscle contractions and whisker vibrations. As stress has been demonstrated to increase both NA and DA in the cerebral cortex [14–16], to rule out the possibility that the effect of LC stimulation might be influenced by stress, we performed the present study in anaesthetized rats. Moreover, we studied whether the release of DA and NA might be differentiated by applying single train or repeated train stimulations.
Mean extracellular basal levels of NA and DA, expressed as pg/sample (40 μl) injected on column were: in the mPFC (n = 25) 4.26 ± 0.49 and 4.34 ± 0.46, in the Occ (n = 26) 4.90 ± 0.65 and 4.22 ± 0.58, in the caudate nucleus (n = 6) 1.71 ± 0.16 and 27.35 ± 3.35 for NA and DA, respectively.
On the other hand, following each stimulation DA remained elevated above the pre-stimulated level when the next stimulation was delivered, therefore the cumulative effect of the repeated stimulation was an increase in DA level by about 40 and 100% in the mPFC and Occ, respectively (ANOVA results: mPFC: F(12,48) = 17.402, P < 0.0001; Occ: F(12,72) = 18.714, P < 0.0001). In the mPFC, DA levels of the third, forth and fifth interval samples resulted significantly different from the sample stimulated previously, while in the Occ no significant difference was found between pauses and stimulations (P < 0.05, Tukey-Kramer multiple comparison test).
At variance to the cortex, in the caudate nucleus only extracellular NA levels were increased by stimulations, returning to baseline during each post-stimulus interval, while DA displayed an oscillatory tendency towards a decrease that reached significant values during the last 3 pauses (ANOVA results: NA: F(12,60) = 10.759, P < 0.0001; DA: F(12,60) = 5.000, P < 0.0001). As described for the cortex, during pauses NA levels were significantly different from the previously stimulated levels, with the exception of the fifth interval sample. Moreover, DA levels displayed a significant difference only between the first stimulated sample and the subsequent pause, although no significant difference was evidenced respect to baseline (P < 0.05, Tukey-Kramer multiple comparison test).
In this research study on anaesthetised animals we found that extracellular basal levels of NA and DA in the mPFC and Occ were analogous to those previously detected in our lab in freely moving rats. Due to the different probe geometry, which may have affected in vivo recovery of catecholamines, comparison of data collected in the mPFC (by means of vertical probes) with data obtained from Occ (by means of horizontal probes) is not appropriate. However, considering each area separately, it appears that while in the mPFC DA and NA concentrations were of a similar magnitude, consistent with the dense dopaminergic innervation of the mPFC, in the Occ DA resulted slightly lower than NA, but higher than one could expect from the scarce, if any, dopaminergic innervation, confirming our previous observations .
Electrical stimulation of the LC produced an increase in both NA and DA concentrations in the cerebral cortex of anaesthetized rats, superimposable to that previously demonstrated by our group in freely moving animals . These data exclude the possibility that stress is involved in electrical stimulation induced catecholamine release.
Our results show that single train and repetitive stimulation of the LC caused a concomitant increase not only of extracellular NA but also of DA in both the mPFC and Occ.
Basal catecholamine levels and stimulation-induced elevations appear to be produced by a nerve-impulse mediated exocytotic process since the local perfusion of TTX dramatically reduced basal levels and totally suppressed the effect of LC stimulation in both cortices. This result exclude the possibility that the increase of extracellular DA originates from a passive leakage of cytosolic DA.
Furthermore, LC stimulation failed to increase DA in the caudate nucleus, which argues against the possibility that midbrain DA neurons might be stimulated by current spread or transynaptically.
NAT displays a high affinity for DA in vitro, and actively reuptakes it from extracellular space [17, 18]. The coupling of NA and DA changes in the mPFC has been explained with the hypothesis that DA changes are secondary to the changes in NA competing with DA for NAT [19–21]. However, against this hypothesis is the finding that following phasic stimulation, DA remained elevated much longer than NA both in the mPFC and to a much longer extent in the OCC.
Moreover, electrical stimulation of the LC produced an increase in DA output when NA uptake had been previously blocked by a NAT inhibitor, both in the mPFC and Occ.
On the other hand, our results indicate that the time course of the release of the two catecholamines may be differentially influenced by the frequency and pattern of noradrenergic activity. Thus, while NA returned to the pre-stimulus level within 20 min after either single train or repeated phasic stimulation, DA elevation persisted for a much longer time. Indeed, repeated stimulation produced a persistent elevation of basal DA both in the mPFC and, to a greater extent, in the OCC. A similar elevation of inter-stimulation levels is also observed for NA during DMI perfusion, leading to the speculation that re-uptake mechanism in vivo is more active in clearing NA than DA, especially in the Occ. In fact, when NAT is blocked by DMI, NA curve approaches the DA one that, on the contrary, displays a similar profile in the absence or in the presence of DMI. A scarce efficacy of NAT in the clearance of DA from extracellular space in the Occ has been already proposed by Valentini et al. .
Another possible explanation for the finding that the duration of DA increase in both cortices exceeded that of NA, is that LC stimulation activates DA synthesis in noradrenergic neurons in excess to that can be converted to NA, due to increase in tyrosine hydroxylase activity following nerve cell stimulation , and consequent possible partial saturation of DA-β-hydroxylase. However, there is no report of this type of saturation, even though evidence exists for a stimulation-induced increase in tyrosine hydroxylase with no change in DA-β-hydroxylase activity in noradrenergic neurons [24–26].
A difficult problem is posed by the finding that DA elevation in the mPFC was of shorter duration than in the parietal cortex. It might be suggested that in the mPFC the DA transporter (DAT), other than NAT, participates in the removal of DA from extracellular space, so that DA removal from mPFC would be more efficient than in the OCC, where DAT is scarce [9, 27]. The latter hypothesis is difficult to test, as the selective DAT inhibitor GBR 12909 has been demonstrated to be ineffective in raising extracellular DA levels in the mPFC [11, 28] even during dopaminergic activity stimulation by means of haloperidol administration . This observation has been explained with the NAT capacity to totally compensate for DAT exclusion, due to the high affinity of DA for NAT [17, 18]. Anyway, this consideration does not exclude that in the mPFC DAT actively reuptakes DA into dopaminergic terminals, thus contributing to decrease extracellular DA levels. Hence, the different profiles of the curves might imply differences in clearance mechanisms for the two catecholamines. MAO A displays higher affinity for NA than for DA , and in the Occ DOPAC is about 10% that found in the mPFC , thus the possibility exists that in the Occ released DA is cleared prevalently by diffusion, instead of being metabolized to DOPAC.
By means of the double probe preparation, we demonstrated that the NA increase produced by LC electrical stimulation is elicited both in the mPFC and caudate nucleus, while DA increase is present in the mPFC but not in the caudate nucleus. Furthermore, when stimulating electrodes were placed outside the LC, no catecholamine increase was observed. Together, these data indicate that DA increase is not due to dopaminergic neuron activation by current spread. Moreover they exclude the possibility that the DA increase observed in the cerebral cortex is due to direct or indirect stimulation of dopaminergic neurons by NA; on the contrary, the DA decrease observed in the caudate nucleus during prolonged stimulation is consistent with an inhibitory action of NA on DA neurons, as already suggested [30, 31]. Such an inhibitory action might contribute to explain why DA elevation in the mPFC was of shorter duration than in the occipital cortex: it might suggest that DA released from noradrenergic terminals was compensated in the mPFC by a reduced DA release from dopaminergic terminals. Indeed, in the caudate nucleus multiple stimulation evidenced a decrease in DA levels.
Finally, the finding that LC stimulation produced the same elevation of DA in areas with high or low dopaminergic innervation, argues against the possibility that a robust portion of extracellular DA, at least in the occipital cortex, might originate from the scarce dopaminergic afferences in these areas.
On the other hand, the co-transmitter hypothesis poses the problem of whether the release of the two catecholamines may be differentially controlled. Indeed, our results indicate that the time course of the release of the two catecholamines may be differentially influenced by the frequency and pattern of noradrenergic activity.
In conclusion, results obtained in the present study provide further evidence that DA in the cerebral cortex satisfies the classic criteria for a candidate co-transmitter in NA neurons. Namely, DA is synthesized, stored, released and recaptured by NA neurons. Notably, the possibility that DA might be released from NA terminals may explain the presence of DA receptors in cortical areas where DA terminals are scarce or absent [3–7].
Our results also suggest that release of DA and NA from NA neurons might be differentially regulated depending on the pattern and frequency of neuronal activity. There is a great deal of evidence for a coupling between the release of DA and NA in the mPFC under different conditions including stress [14–16], antidepressants [32, 33], psychostimulants [34, 35], antipsychotic drugs [9, 36, 37], α2-adrenoceptor agonists and antagonists [8, 10, 11, 38].
It would be of great interest to determine whether such coupling occurs in cortices outside the canonical mPFC, whether it represents the co-release of the two catecholamines from noradrenergic terminals, if the release of the two can be differentially controlled, and to understand the functional significance of such coupling.
The experiments were performed on male Sprague-Dawley rats (Harlan Italy, S. Pietro al Natisone, Italy) weighing 270–300 g, housed in groups of 5 per cage prior to surgery and singly afterwards, at standard conditions of temperature and humidity and artificial light from 8 a.m. to 8 p.m.; food and water were available ad libitum. Experiments were approved by the local ethical committee and performed according to the guidelines for care and use of experimental animals of the UE (EEC Council 86/609; D.L. 27/01/1992, n. 116). Each animal, under Equithesin anesthesia (0.97 g pentobarbital, 2.1 g MgSO4, 4.25 g chloral hydrate, 42.8 ml propylene glycol, 11.5 ml 90% ethanol, distilled water up to 100 ml), was stereotaxically implanted, according to the coordinates of the atlas by Paxinos and Watson , with one vertical microdialysis probe in the mPFC (A +3.0, L ± 0.7, V -6.5, 4 mm active membrane length), or one transversal microdialysis probe in the OCC (A -5.0, V-1.8 from bregma, 4 mm active membrane length, corresponding to one hemisphere), or with two probes, a vertical one in the mPFC and a horizontal one in the homolateral OCC. In another group of animals, two vertical probes were inserted, one in the mPFC and one in the homolateral caudate nucleus (A +0.5, L ± 3.0, V -6.5 from bregma, 4 mm active membrane length). Dialysis membrane was AN 69-HF, Hospal-Dasco, Bologna, Italy; the in vitro recovery ranged from 14 to 20% for both DA and NA.
The day after probe implantation, animals were anaesthetized with chloral hydrate (400 mg/kg i.p.) and placed in a Kopf stereotaxic apparatus, where they remained throughout the experiment. Body temperature was maintained at 37°C with a heating pad, and anesthesia was maintained with a continuous infusion of chloral hydrate (400 mg/5 ml, i.p. infused at 0.28 ml/h). A standard bipolar stimulant electrode (Rhodes SNEX-100, Harvard Apparatus, Edenbridge, UK) was implanted in the locus coeruleus (A -3.1, V -8.4, L ± 1.3 from lambda, entering at 15° angle), homolateral to the vertical probes or to the dialyzing portion of the horizontal probe. Stimulant electrodes were connected to a Digitimer (Welwyn Garden City, UK) D4030 stimulus generator and the stimuli were delivered through a DC constant current generator-isolation unit Digitimer DS3. Stimuli were delivered in bursts (trains of 3 spikes regularly spaced in 250 msec, one train per sec) at an intensity of 700 μA, each spike lasting 250 μsec. This stimulation pattern was chosen, on the basis of previous results , as it elicited a consistent catecholamine increase with the least behavioural activation. Each rat received 1 stimulation train lasting 20 min or a sequence of 5 stimulation trains, spaced with 20 min pauses.
An artificial cerebrospinal fluid (147 mM NaCl, 4 mM KCl, 1.5 mM CaCl2, pH 6–6.5) was pumped through the dialysis probes at a constant rate of 2.2 μl/min via a CMA/100 microinjection pump (Carnegie Medicine, Stockholm, Sweden). Tetrodotoxin (TTX) and desipramine (DMI), purchased from Sigma-Aldrich (Milan, Italy), were dissolved in the artificial cerebrospinal fluid and administered by inverse dialysis at 10 and 100 μM concentration, respectively.
Samples were collected every 20 min, and NA and DA simultaneously analysed by high performance liquid chromatography (HPLC) apparatus with electrochemical detection, equipped with a 3.0 × 150 mm C18 (5 μ) Symmetry column (Waters) and an ESA Coulochem II detector. The mobile phase consisted of 80 mM Na2HPO4, 0.27 mM EDTA, 0.58 mM sodium octyl sulphate, 12% methanol, pH 2.8 with H3PO4, delivered by a model 307 Gilson pump at 0.4 ml/min; the Coulochem analytical cell first electrode was set at +200 mV, the second at -300 mV. In these conditions, the detection limits (signal to noise ratio 3:1) were 0.3 pg of NA and DA on column.
The average concentration of three stable samples (less than 15% variation) before treatment was considered as the control and was defined as 100%. Thus, values are expressed as percentages of controls + S.E.M.
On termination of experiments, rats were killed with an overdose of chloral hydrate (1.2 g/kg), the brains were removed and stored with 10% formalin in 0.2 M phosphate buffer until histologically verified; coronal sections (40 μm thick) were made with a Vibratome, oriented according to the atlas of Paxinos and Watson , stained with fast cresyl violet stain and the location of probes and electrodes was verified according to the above atlas. While no probe resulted outside the correct sampling area, electrodes were found outside the locus coeruleus in 8 out of 59 rats, the data from which were discarded, with the exception of data obtained in 3 of these rats that are shown separately.
Statistical significance was evaluated by analysis of variance (ANOVA) for repeated measures, followed by Dunnett multiple comparison test.
- Descarries L, Lemay B, Doucet G, Berger B: Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience. 1987, 21: 807-824. 10.1016/0306-4522(87)90038-8.View ArticlePubMedGoogle Scholar
- Seguela P, Watkins KC, Geffard M, Descarries L: Noradrenaline axon terminals in adult rat neocortex: an immunohistochemical analysis in serial thin sections. Neuroscience. 1990, 35: 249-264. 10.1016/0306-4522(90)90079-J.View ArticlePubMedGoogle Scholar
- Martres MP, Bouthenet ML, Sales N, Sokoloff P, Schwartz JC: Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpiride, a highly selective ligand. Science. 1985, 228: 752-755.View ArticlePubMedGoogle Scholar
- Lidow MS, Goldman-Rakic PS, Rakic P, Innis RB: Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Proc Natl Acad Sci USA. 1989, 86: 6412-6416.PubMed CentralView ArticlePubMedGoogle Scholar
- Richfield EK, Young AB, Penney JB: Comparative distribution of dopamine D1 and D2 receptors in the cerebral cortex of rats, cats and monkeys. J Comp Neurol. 1989, 286: 409-26. 10.1002/cne.902860402.View ArticlePubMedGoogle Scholar
- Goldsmith SK, Joyce JN: Dopamine D2 receptors in hippocampus and parahippocampal cortex of rat, cat and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus. 1994, 4: 354-373.View ArticlePubMedGoogle Scholar
- Wedzony K, Chocyk A, Mackowiak M, Fijal K, Czyrak A: Cortical localization of dopamine D4 recetros in the rat brain – Immunocytochemical study. J Physiol Pharmacol. 2000, 51: 205-221.PubMedGoogle Scholar
- Devoto P, Flore G, Pani L, Gessa GL: Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry. 2001, 6: 657-664. 10.1038/sj.mp.4000904.View ArticlePubMedGoogle Scholar
- Devoto P, Flore G, Vacca G, Pira L, Arca A, Casu MA, Pani L, Gessa GL: Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacology (Berl). 2003, 167: 79-84.Google Scholar
- Devoto P, Flore G, Longu G, Pira L, Gessa GL: Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse. 2003, 50: 200-205. 10.1002/syn.10264.View ArticlePubMedGoogle Scholar
- Devoto P, Flore G, Longu G, Pira L, Gessa GL: Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J Neurochem. 2004, 88: 1003-1009.View ArticlePubMedGoogle Scholar
- Devoto P, Flore G, Saba P, Fà M, Gessa GL: Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem. 2005, 92: 368-374. 10.1111/j.1471-4159.2004.02866.x.View ArticlePubMedGoogle Scholar
- Kawahara H, Kawahara Y, Westerink BHC: The noradrenaline-dopamine interactions in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur J Pharmacol. 2001, 418: 177-186. 10.1016/S0014-2999(01)00863-9.View ArticlePubMedGoogle Scholar
- Kawahara Y, Kawahara H, Westerink BHC: Comparison of the effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1999, 360: 42-49. 10.1007/s002109900042.View ArticlePubMedGoogle Scholar
- Feenstra MG: Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog Brain Res. 2000, 126: 133-163.View ArticlePubMedGoogle Scholar
- Murphy EK, Sved AF, Finlay JM: Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex of control or chronically stressed rats. Neuroscience. 2003, 116: 1081-1087. 10.1016/S0306-4522(02)00565-1.View ArticlePubMedGoogle Scholar
- Horn AS: Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenergic and dopaminergic neurons in rat brain homogenates. Br J Pharmacol. 1973, 47: 332-338.PubMed CentralView ArticlePubMedGoogle Scholar
- Raiteri M, Del Carmine R, Bertollini A, Levi G: Effects of sympaticomimetic amines on the synaptosomal transport of noradrenaline, dopamine, 5-hydroxytryptamine. Eur J Pharmacol. 1977, 41: 133-143. 10.1016/0014-2999(77)90202-3.View ArticlePubMedGoogle Scholar
- Carboni E, Tanda GL, Frau R, Di Chiara G: Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem. 1990, 55: 1067-1070.View ArticlePubMedGoogle Scholar
- Pozzi L, Invernizzi R, Cervo L, Vallebuona F, Samanin R: Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J Neurochem. 1994, 63: 195-200.View ArticlePubMedGoogle Scholar
- Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT: Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci. 2002, 22: 389-395.PubMedGoogle Scholar
- Valentini V, Frau R, Di Chiara G: Noradrenaline transporter blockers raise extracellular dopamine in the medial prefrontal but not parietal and occipital cortex: differences with mianserine and clozapine. J Neurochem. 2004, 88: 917-927.View ArticlePubMedGoogle Scholar
- Zigmond RE, Schwarzschild MA, Rittenhouse A: Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorilation. Ann Rev Neurosci. 1989, 12: 415-461. 10.1146/annurev.ne.12.030189.002215.View ArticlePubMedGoogle Scholar
- Anden N-E, Grabowska-Anden M: Synthesis and utilization of catecholamines in the rat superior cervical ganglion following changes in the nerve impulse flow. J Neural Transm. 1985, 64: 81-92. 10.1007/BF01245970.View ArticlePubMedGoogle Scholar
- Lewander T, Joh TH, Reis DJ: Tyrosine hydroxylase: delayed activation in central noradrenergic neurons and induction in adrenal medulla elicited by stimulation of central cholinergic receptors. J Pharmacol Exp Ther. 1977, 200: 523-534.PubMedGoogle Scholar
- Kilbourne EJ, Sabban EL: Differential effect of membrane depolarization on levels of tyrosine hydroxylase and dopamine β-hydroxylase mRNAs in PC12 pheochromocytoma cells. Mol Brain Res. 1990, 8: 121-127. 10.1016/0169-328X(90)90056-J.View ArticlePubMedGoogle Scholar
- Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI: The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci. 1995, 15: 1714-1723.PubMedGoogle Scholar
- Mazei MS, Pluto CP, Kirkbride B, Pehek EA: Effect of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res. 2002, 936: 58-67. 10.1016/S0006-8993(02)02542-8.View ArticlePubMedGoogle Scholar
- Trendelenburg U: The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol. 1989, 339: 293-297. 10.1007/BF00173580.View ArticlePubMedGoogle Scholar
- Grenhoff J, Nisell M, Ferré S, Aston-Jones G, Svensson TH: Noradrenergic modulation of dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect. 1993, 93: 11-25. 10.1007/BF01244934.View ArticlePubMedGoogle Scholar
- Paladini CA, Williams JT: Noradrenergic inhibition of midbrain dopamine neurons. J Neurosci. 2004, 24: 4568-4575. 10.1523/JNEUROSCI.5735-03.2004.View ArticlePubMedGoogle Scholar
- Millan MJ, Gobert A, Rivet J-M, Adhumeau-Auclair A, Cussac D, Newman-Tancredi A, Dekeyne A, Nicolas J-P, Lejeune F: Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci. 2000, 12: 1079-1095. 10.1046/j.1460-9568.2000.00982.x.View ArticlePubMedGoogle Scholar
- Devoto P, Flore G, Pira L, Longu G, Gessa GL: Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol. 2004, 487: 105-111. 10.1016/j.ejphar.2004.01.018.View ArticlePubMedGoogle Scholar
- Roberts DC, Zis A, Fibiger HC: Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res. 1975, 93: 441-454. 10.1016/0006-8993(75)90182-1.View ArticlePubMedGoogle Scholar
- Darracq L, Blanc G, Glowinski J, Tassin J-P: Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci. 1998, 18: 2729-2739.PubMedGoogle Scholar
- Westerink BHC, de Boer P, de Vries JB, Kruse CG, Long SK: Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur J Pharmacol. 1998, 361: 27-33. 10.1016/S0014-2999(98)00711-0.View ArticlePubMedGoogle Scholar
- Li XM, Perry KW, Wong DT, Bymaster FP: Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology (Berl). 1998, 136: 153-161. 10.1007/s002130050551.View ArticleGoogle Scholar
- Gresch PJ, Sved AF, Zigmond MJ, Finlay JM: Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem. 1995, 65: 111-116.View ArticlePubMedGoogle Scholar
- Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 1997, Academic Press, San Diego, California, 3Google Scholar